COVID-19: Centre doesn’t clarify basis for CDSCO authorising remdesivir
Government also does not provide clarity about whether remdesivir should be given to only severe patients
US approves new drug that can cure even drug resistant TB
Experts, activists seek new regime for its rational use
COVID-19: US FDA grants emergency authorisation for remdesivir
EUA doesn't equal final nod; China trial painted different picture